Kevin D. Bunker - Jul 20, 2022 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Signature
By: /s/ Melissa B. Epperly, Attorney-in-Fact for Kevin D. Bunker
Stock symbol
ZNTL
Transactions as of
Jul 20, 2022
Transactions value $
-$150,000
Form type
4
Date filed
7/20/2022, 08:28 PM
Previous filing
Jul 14, 2022
Next filing
Aug 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZNTL Common Stock Sale -$150K -5K -4.76% $30.00 100K Jul 20, 2022 See Footnote F1, F2
holding ZNTL Common Stock 764K Jul 20, 2022 Direct
holding ZNTL Common Stock 350 Jul 20, 2022 As UTMA custodian for sons
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021.
F2 Represents shares nominally held by Sundog Ranch, Inc. on behalf of the Bunker Family Protection Trust, the sole shareholder of Sundog Ranch, Inc. The Reporting Person and his wife are the primary beneficiaries of the Bunker Family Protection Trust and the Reporting Person and his wife are also directors of Sundog Ranch, Inc. The Reporting Person disclaims beneficial ownership of the securities held by Sundog Ranch, Inc. except to the extent of his pecuniary interest therein, if any.